Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...
A new oral medication called Xocova has become the first FDA-approved post-exposure COVID pill, cutting infection risk by 67 ...
Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available ...
CLEVELAND — Researchers at the University of Cincinnati and the Icahn School of Medicine at Mount Sinai have identified two weather patterns most likely to trigger headaches: an approaching cold front ...
A new COVID-19 pill is hitting the market. It's different from past coronavirus medications and antivirals, and it has the potential to be an absolute game-changer. The U.S. Food and Drug ...